Prostate cancer ranks among the most prevalent types of cancer affecting men, yet it often progresses silently without early symptoms. As the condition advances, the growing tumor can impact nearby organs such as the bladder and urethra, resulting in noticeable changes in urinary and reproductive functions.
Early indicators of potential issues include alterations in urination patterns. These changes might manifest as an increased need to urinate, especially at night, urgency, a weak or inconsistent urine stream, trouble initiating urination, or the sensation of an incompletely emptied bladder. Understanding these symptoms is crucial, as they can serve as the first hints of an underlying problem.
Men may also experience discomfort or pain during urination or ejaculation, which can be a sign of prostate complications. If these symptoms persist, they warrant medical attention. A more alarming symptom is the presence of blood in urine or semen, which should prompt immediate medical investigation, as it can be linked to prostate cancer or other significant health issues.
In its more advanced stages, prostate cancer may extend beyond the prostate gland itself, potentially resulting in persistent pain in areas such as the hips, spine, or chest. Other signs of progression include unexplained weight loss and sudden erectile dysfunction. Although these symptoms can sometimes be attributed to benign conditions like prostate enlargement or infection, a thorough medical assessment is essential to rule out cancer.
Men should be vigilant for persistent urinary alterations, pelvic pain, or any of the aforementioned symptoms, and seek medical guidance accordingly. Immediate medical intervention is advised for those experiencing visible blood in urine or semen, sudden difficulty urinating, or severe back or pelvic pain accompanied by leg weakness or numbness. Regular screening is crucial, and men at average risk are generally advised to discuss prostate cancer screening, including the PSA blood test, with their healthcare provider starting at age 50. Those with a close family history of the disease should consider initiating these discussions earlier, around age 45.